Clinical Trial Update: Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on magnetic resonance-guided high-dose brachytherapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Magnetic resonance-guided high-dose brachytherapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED